Generation Bioco Stock Retained Earnings
| GBIO Stock | USD 3.37 0.02 0.59% |
Generation BioCo fundamentals help investors to digest information that contributes to Generation BioCo's financial success or failures. It also enables traders to predict the movement of Generation Stock. The fundamental analysis module provides a way to measure Generation BioCo's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Generation BioCo stock.
| Last Reported | Projected for Next Year | ||
| Retained Earnings | -571.4 M | -542.8 M | |
| Retained Earnings Total Equity | -400.3 M | -420.3 M |
Generation | Retained Earnings |
Generation BioCo Company Retained Earnings Analysis
Generation BioCo's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Generation BioCo Retained Earnings | (571.38 M) |
Most of Generation BioCo's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Generation BioCo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generation Retained Earnings Driver Correlations
Understanding the fundamental principles of building solid financial models for Generation BioCo is extremely important. It helps to project a fair market value of Generation Stock properly, considering its historical fundamentals such as Retained Earnings. Since Generation BioCo's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Generation BioCo's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Generation BioCo's interrelated accounts and indicators.
Click cells to compare fundamentals
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Generation BioCo has a Retained Earnings of (571.38 Million). This is 161.35% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The retained earnings for all United States stocks is 106.12% higher than that of the company.
Generation Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Generation BioCo's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Generation BioCo could also be used in its relative valuation, which is a method of valuing Generation BioCo by comparing valuation metrics of similar companies.Generation BioCo is currently under evaluation in retained earnings category among related companies.
Generation BioCo Current Valuation Drivers
We derive many important indicators used in calculating different scores of Generation BioCo from analyzing Generation BioCo's financial statements. These drivers represent accounts that assess Generation BioCo's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Generation BioCo's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.1B | 772.7M | 398.6M | 228.4M | 262.7M | 249.5M | |
| Enterprise Value | 1.1B | 709.8M | 104.3M | 216.9M | 249.5M | 237.0M |
Generation BioCo ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Generation BioCo's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Generation BioCo's managers, analysts, and investors.Environmental | Governance | Social |
Generation Fundamentals
| Return On Equity | -0.82 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (5.10) % | ||||
| Current Valuation | 102.17 M | ||||
| Shares Outstanding | 66.53 M | ||||
| Shares Owned By Insiders | 14.55 % | ||||
| Shares Owned By Institutions | 83.29 % | ||||
| Number Of Shares Shorted | 1.75 M | ||||
| Price To Book | 1.21 X | ||||
| Price To Sales | 41.66 X | ||||
| Revenue | 5.9 M | ||||
| EBITDA | (133.3 M) | ||||
| Net Income | (126.61 M) | ||||
| Cash And Equivalents | 301.17 M | ||||
| Cash Per Share | 5.07 X | ||||
| Total Debt | 97.89 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 17.93 X | ||||
| Book Value Per Share | 1.99 X | ||||
| Cash Flow From Operations | (52.74 M) | ||||
| Short Ratio | 7.22 X | ||||
| Earnings Per Share | (2.55) X | ||||
| Target Price | 7.5 | ||||
| Number Of Employees | 174 | ||||
| Beta | 2.87 | ||||
| Market Capitalization | 225.53 M | ||||
| Total Asset | 374.76 M | ||||
| Retained Earnings | (571.38 M) | ||||
| Working Capital | 232.7 M | ||||
| Net Asset | 374.76 M |
About Generation BioCo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Generation BioCo's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Generation BioCo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Generation BioCo based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Generation BioCo Piotroski F Score and Generation BioCo Altman Z Score analysis. To learn how to invest in Generation Stock, please use our How to Invest in Generation BioCo guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Generation Stock analysis
When running Generation BioCo's price analysis, check to measure Generation BioCo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Generation BioCo is operating at the current time. Most of Generation BioCo's value examination focuses on studying past and present price action to predict the probability of Generation BioCo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Generation BioCo's price. Additionally, you may evaluate how the addition of Generation BioCo to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Generation BioCo's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation BioCo. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation BioCo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.55) | Revenue Per Share 0.151 | Return On Assets (0.22) | Return On Equity (0.82) |
The market value of Generation BioCo is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation BioCo's value that differs from its market value or its book value, called intrinsic value, which is Generation BioCo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation BioCo's market value can be influenced by many factors that don't directly affect Generation BioCo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation BioCo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation BioCo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation BioCo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.